-
Product Insights
Premature Ovarian Failure Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Premature Ovarian Failure Global Clinical Trials Review, H1, 2018" provides an overview of Premature Ovarian Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Premature Ovarian Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Premenstrual Dysphoric Disorder (PMDD) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Premenstrual Dysphoric Disorder (PMDD) Global Clinical Trials Review, H1, 2018" provides an overview of Premenstrual Dysphoric Disorder (PMDD) clinical trials scenario. This report provides top line data relating to the clinical trials on Premenstrual Dysphoric Disorder (PMDD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Premenstrual Syndrome Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Premenstrual Syndrome Global Clinical Trials Review, H1, 2018" provides an overview of Premenstrual Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Premenstrual Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Primary Dysmenorrhea Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Primary Dysmenorrhea Global Clinical Trials Review, H1, 2018" provides an overview of Primary Dysmenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Dysmenorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Primary Dysmenorrhea Disease - Global Clinical Trials Review, H2 2019
GlobalData's clinical trial report, “Primary Dysmenorrhea Global Clinical Trials Review, H2, 2019" provides an overview of Primary Dysmenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Dysmenorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Contraceptives: Opportunity Analysis and Forecasts to 2027
Hormonal contraceptives are primarily used to prevent unintended pregnancy; however, some of these contraceptives are also approved or used off-label for other health conditions, particularly menstrual-related disorders. This report focuses on female hormonal contraceptives used for birth control as well as other non-contraceptive benefits distinct from their ability to prevent pregnancy. Female hormonal contraceptives are used in women of reproductive age, which according to the World Health Organization (WHO) refers to all women ages 15–49 years. GlobalData estimates the 2017...
-
Sector Analysis
OpportunityAnalyzer: Endometriosis – Opportunity Analysis and Forecast to 2025
Endometriosis is an estrogen-dependent, chronic, inflammatory disease characterized by the appearance and growth of endometrial cells or tissues in locations outside the uterus. It is a common gynecological condition; however the disease is underdiagnosed due to the invasive nature of laparoscopy that confirms diagnosis. GlobalData estimates the endometriosis prevalence, including suspected and confirmed cases, to grow from 9.6 million to 11.3 million worldwide between 2015 and 2025. Current FDA-approved therapies for endometriosis comprise drugs that suppress ovulation and/or induce a...
-
Sector Analysis
Female Infertility - Opportunity Analysis and Forecasts to 2028
Female infertility (FI) is a complex disorder defined as the inability to conceive after at least one year of timed, unprotected intercourse. The etiology of the condition spans a wide range of disorders that can be broadly classified into the following categories: diminished ovarian reserve & ovulation disorders, endometriosis, fallopian tube abnormalities, uterine factors and unexplained infertility. Several factors may be considered before a treatment decision is made, including treatment effectiveness (live birth rate), treatment burden (such as number of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.